News | April 15, 2009

Zecotek Photonics Earns Frost & Sullivan Enabling Technology Award

April 15, 2009 - Based on its recent analysis of the U.S. PET and PET/CT markets, Frost & Sullivan awarded Zecotek Photonics Inc. with its 2009 North American Frost & Sullivan Award for Enabling Technology.

According to Frost & Sullivan, Zecotek's outstanding research and development has brought forth innovative scintillation crystal and solid-state photo detector technologies that will help deliver cutting-edge oncology, neurology and cardiology imaging equipment.

"Zecotek is favorably positioned as a global competitor, having been issued or allowed patents for its lutetium fine silicate (LFS) scintillation crystals in many countries and a series of pending and granted patents for its novel solid-state photomultiplier and Depth of Interaction design considerations," said Travis Chong, an industry analyst for Frost & Sullivan. "The company is integrating all these components into what it has dubbed the 'Plug to Socket', a very compact detector module element that captures high resolution images, is easy to install, and requires very low servicing."

Zecotek has emerged as a leader in developing affordable, sophisticated photodetector and solid-state technologies for PET/CT and other medical applications. The company first set the standard with its micro-pixel avalanche photo diode (MAPD)-1 concept, whose design and performance characteristics served as a solid-state photodetector design template for the industry over the last several years. The MAPD-1 eventually evolved into the MAPD-2 and MAPD-3, providing better electrical efficiency and imaging capabilities than traditional integrated photo multiplier tubes (PMTs) in scanners.

For more information: www.frost.com, www.zecotek.com


Related Content

News | PET Imaging

October 5, 2023 β€” Jubilant DraxImage Inc., a wholly-owned subsidiary of Jubilant Pharma Limited, has entered into an ...

Home October 05, 2023
Home
News | PET Imaging

December 1, 2022 β€” A new method for determining whether patients with heart disease need coronary stents or bypass ...

Home December 01, 2022
Home
News | PET Imaging

September 14, 2022 β€” GE Healthcare and Lantheus Holdings Inc have announced that the recent Phase III clinical trial of ...

Home September 14, 2022
Home
News | PET Imaging

August 25, 2022 β€” The results of β€œA Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...

Home August 25, 2022
Home
News | PET Imaging

June 15, 2022 β€” Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI ...

Home June 15, 2022
Home
Technology | PET Imaging

December 5, 2018 β€” Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ...

Home December 05, 2018
Home
News | PET Imaging

July 17, 2018 β€” A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new ...

Home July 17, 2018
Home
News | PET Imaging

July 7, 2017 β€” Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are ...

Home July 07, 2017
Home
News | PET Imaging

March 3, 2017 β€” In the featured article of the March 2017 issue of The Journal of Nuclear Medicine, researchers ...

Home March 03, 2017
Home
News | PET Imaging

September 1, 2016 β€” The American Society for Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...

Home September 01, 2016
Home
Subscribe Now